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Introduction {#sec1}
============

Actin is one of the most abundant eukaryotic proteins ([@bib1]) and plays key roles in intracellular transport, cell signaling, cellular shape changes, and cell motility ([@bib2]). These processes involve controlled actin polymerization and depolymerization, as well as actin-myosin interactions ([@bib3]). Force and motion generation involving different isoforms of myosin II motors and actin filaments (F-actin) is central in all cells and the basis for muscle contraction. In this process, the actin filaments are often viewed as rope-like passive interaction partners ([@bib4]) despite evidence from spectroscopy, ultrastructural studies, and myosin-binding data indicating that the actin filament structure is dependent on myosin head attachment and the state of the attached myosin motor domains ([@bib1], [@bib3], [@bib5], [@bib6], [@bib7], [@bib8], [@bib9], [@bib10], [@bib11], [@bib12], [@bib13], [@bib14], [@bib15], [@bib16], [@bib17], [@bib18]).

One way to detect changes in the actin filament state is to monitor the filament flexural rigidity, EI, because E (the Young's modulus) and I (the second moment of inertia of the filament cross section) reflect the intermonomer interaction strength and filament geometry, respectively ([@bib18]). The flexural rigidity is a measure of the resistance to bending and is often quantified using the persistence length, *L*~*P*~^*f*^. This is a characteristic correlation length for thermal bending fluctuations along the filament that is related to the flexural rigidity as *L*~*P*~^*f*^ = EI/kT (where k is the Boltzmann constant and T is the absolute temperature). For example, two different flexibility states of actin filaments have been found with different nucleotides bound to the actin subunits in the presence and absence of phalloidin or with and without binding of myosin ([@bib5], [@bib6], [@bib9], [@bib10], [@bib19], [@bib20], [@bib21]). Recently, evidence was presented for what seems to be a third flexibility state with even higher flexibility (lower *Lp*^*f*^), e.g., after cofilin binding ([@bib22]) or after tethering of the filaments to a surface via proteins that bind along the actin filament side ([@bib23]). This is consistent with ideas of a strongly dynamic actin filament ([@bib1], [@bib7], [@bib8], [@bib24]). However, these ideas are not unequivocally supported ([@bib25], [@bib26]) (discussion in ([@bib1])), and no marked difference in filament flexibility between different conditions of myosin-induced actin motility has been observed previously.

In an in vitro motility assay (IVMA), fluorescence-labeled actin filaments are propelled by surface-adsorbed myosin molecules ([@bib27], [@bib28]), or rather, myosin motor fragments such as heavy meromyosin (HMM). A convenient way to describe the statistics of the winding filament paths is to use the path persistence length (*Lp*^*p*^) ([@bib5], [@bib29], [@bib30]), which is the sliding distance after which the memory of the initial tangent angle of the path is effectively lost. Recent results ([@bib5], [@bib31], [@bib32], [@bib33]) provide strong evidence that the *Lp*^*p*^ corresponds directly to the *Lp*^*f*^, i.e., it is determined by the flexural rigidity of the actin filaments. On this basis, we concluded that the flexural rigidity of phalloidin-stabilized actin filaments is reduced to the level of phalloidin-free filaments when the former are propelled by HMM at ionic strengths of \<100 mM, but not at a higher ionic strength (130 mM) ([@bib5]). We hypothesized that this discrepancy is due to the failure of myosin-induced structural changes to propagate along the actin filaments at high ionic strength ([@bib5]). If this is indeed the case, increased density of active myosin heads along the actin filament would be expected to make *Lp*^*p*^ more similar for phalloidin-free and phalloidin-stabilized filaments.

In conflict with the notion that the actin filament paths in an IVMA are fully determined by thermal fluctuations that reflect *Lp*^*f*^, a recent study ([@bib34]) suggested that nonthermal fluctuations due to motor-induced forces are important. These forces were largely attributed to motors temporarily acting as cross-linkers between the filament and the surfaces, e.g., as would be expected for cross-bridges in postpowerstroke states. Therefore, a change in the fraction of such motors may be expected to modify the filament paths.

Experiments using lowered MgATP concentrations allowed us to test the above ideas. This intervention reduces the rate of myosin head detachment from actin without changing the attachment rate constant ([@bib35]), causing an increased density of the attached myosin heads (cf. Fig. 2 in ([@bib35])) with the leading head being closer to the filament front. This would facilitate the propagation of myosin-induced structural changes to the free leading end. Furthermore, lowered \[MgATP\] would increase the fraction of myosin heads in the postpowerstroke state, which is expected to influence nonthermal contributions to the filament trajectories ([@bib34]). As an alternative approach to increase the fraction of such braking cross-bridges, we mixed functional HMM with HMM that had been made ATP insensitive and noncycling by treatment with N-ethylmaleimide (hereafter termed NEM-HMM).

Unexpectedly, we found a substantial reduction in *L*~*P*~^*p*^ by lowering \[MgATP\] from 1 to 0.05 mM. The observed effect was considerably greater than would be expected according to the hypothesis of improved propagation of structural changes. Together with the effects of HMM and phalloidin on *Lp*^*f*^, this finding is consistent with three mechanically distinct actin filament states. Among these states, the one with the lowest flexural rigidity (at low \[MgATP\]) has not, to the best of our knowledge, been observed previously for HMM-propelled filaments. Additionally, our results are consistent with local structural changes occurring in the actin filament upon each myosin head attachment. Finally, we found evidence for a substantially reduced frequency of bursts with an anomalous nonthermal influence ([@bib34]) on the filament paths at low \[MgATP\]. This was in contrast to the increase of such an influence after addition of NEM-HMM at 1 mM MgATP. The results are consistent with the idea that reduced *Lp*^*p*^ at lowered \[MgATP\] to a substantial degree reflects reduced *Lp*^*f*^, whereas a nonthermal influence relies on the presence of a fraction of noncycling myosin heads. Overall, the results are consistent with a dynamic actin filament whose global and local structure is affected by actin-myosin interaction kinetics. We discuss the mechanisms that promote the formation of a high-flexibility state at low \[MgATP\] and also consider the properties of this state in relation to key cellular functions and adaptations.

Materials and Methods {#sec2}
=====================

Ethics statement {#sec2.1}
----------------

All experiments using animal material were approved by the Regional Ethics Committee for Animal Experiments in Linköping, Sweden (reference numbers 58-08, 96-11, and 73-14), and performed in accordance with national and European Union legislations.

Protein preparations and IVMAs {#sec2.2}
------------------------------

HMM was obtained from fast skeletal muscle myosin, and actin was prepared from acetone powder from skeletal muscle ([@bib28], [@bib36]). Actin filaments were formed by addition of KCl (50 mM) and MgCl~2~ (2 mM), and in some cases MgATP (3 mM), with no apparent difference in the results. The filaments were treated with tetramethylrhodamine isothiocyanate phalloidin (TRITC-Ph) at molar excess or were fluorescence labeled using N-hydroxysuccinimide rhodamine (NHS-Rh) without phalloidin ([@bib5]). NEM-HMM was obtained as described previously ([@bib37], [@bib38], [@bib39]). Briefly, HMM (∼500 *μ*g/mL) was dialyzed against imidazole-EDTA buffer (10 mM imidazole, 50 mM KCl, 10 mM EDTA, pH 7.0) using a centrifugal concentrator (Vivaspin 2, 28-9322-47; GE Healthcare, Little Chalfont, UK), and treated with NEM (1 mM final concentration; E1271; Sigma-Aldrich, St. Louis, MO) dissolved in ethanol and diluted with the imidazole-EDTA buffer. After incubation for 1 h at 25°C, the NEM-HMM was dialyzed against imidazole-EDTA buffer for removal of excess NEM. The concentration of NEM-HMM was measured using a Bradford assay. The proteins were stored at −80°C until use. The method that we generally use for HMM preparation yields submicromolar concentrations. For some experiments, the HMM concentration was increased to 3--5 *μ*M by a procedure in which HMM (∼0.5 *μ*M) was centrifuged at 14,000 × *g* for 29 min at 4°C using 30 kD cutoff membranes (Nanosep Centrifugal Devices; Pall, Port Washington, NY). The concentrated HMM had similar actin-propelling properties (velocity and fraction of motile filaments) as before the concentration procedure, as tested in separate experiments.

For the IVMAs, glass coverslips functionalized with trimethylchlorosilane (TMCS) ([@bib40]) were assembled into flow cells that were incubated with HMM (for 2 min), followed by a number of rinsing and blocking steps before addition of 2--10 nM fluorescently labeled actin filaments (30 s). Subsequently, an assay solution containing 0.01--3 mM MgATP, 2.5 mM creatine phosphate, 56 U mL^−1^ creatine kinase, 0.64% methylcellulose, and 115 mM KCl was added. The flow-cell temperature varied between 25.2°C and 29.1°C between different assays. The IVMA conditions were similar to those previously described as important for unbiased studies of path persistence lengths ([@bib30]). Motility assays with 25% and 30% NEM-HMM out of the total amount of HMM were performed in the presence of 1 mM MgATP, and other experimental conditions were similar to those employed in standard IVMAs.

The image sequences were recorded using an EM-CCD camera (C9100; Hamamatsu Photonics, Hamamatsu, Japan) with a pixel magnification of 0.165 × 0.165 *μ*m^2^ per pixel, or a cooled CCD camera (Orca-ER, C4742-95; Hamamatsu Photonics) with a pixel magnification of 0.198 × 0.198 *μ*m^2^ per pixel, at frame rates of 5--10 s^−1^ as appropriate. See [Supporting Materials and Methods](#mmc1){ref-type="supplementary-material"} in the [Supporting Material](#app2){ref-type="sec"} for details.

Persistence lengths of actin filament paths and actin filaments in solution {#sec2.3}
---------------------------------------------------------------------------

The path persistence length (*L*~*P*~) of the actin filaments in the IVMA was obtained ([@bib5], [@bib30]) on the basis of the cosine correlation function (CCF), \<cos(*θ*(*s*) − *θ*(0))\> (where *θ*(*s*) is the instantaneous sliding direction), plotted against the distance (*s*) along the filament path. An algorithm developed in MATLAB (The MathWorks, Natick, MA) was used to manually track the filaments to obtain *θ*(*s*) and *s*. Filaments stuck on dead rigor-like HMM heads or filaments undergoing abrupt direction changes (defined by a cutoff value set to 1.5 radians) were excluded before the CCF was fitted ([@bib30]). The *L*~*P*~ value was obtained from fits of the following equation to the data:$$\left\langle {\text{cos}\left( {\theta\left( \text{s} \right)\text{-}\theta\left( 0 \right)} \right)} \right\rangle = \text{exp}\left( {{\text{-}\text{s}}/\left\lbrack {2 \ast \text{Lp}} \right\rbrack} \right).$$A similar principle was used to obtain the persistence length of actin filaments in solution, aside from using the instantaneous tangent angle at positions *s* along the filament instead of the tangent angle along the path. For these measurements, actin was diluted to a concentration of 5--40 nM in an assay buffer-based solution but without methylcellulose and MgATP. To create a flow cell of \<5 *μ*m thickness, 3--5 *μ*L of the actin sample was sandwiched between a small coverslip (18 × 18 mm^2^) and a glass slide. The surfaces were soaked in bovine serum albumin and dried before use. For measurements in the presence of HMM, polyethylene glycol (PEG)-derivatized surfaces ([Supporting Materials and Methods](#mmc1){ref-type="supplementary-material"}) ([@bib41]) were used to prevent HMM adsorption to the surfaces. In this case, 1--5 *μ*L of the actin+HMM+MgATP sample was sandwiched between the two PEG-coated glass slides (20 × 20 mm^2^). In all cases, the flow cells were sealed with nail polish before measurements were obtained at room temperature (20--23°C), and images were recorded with a 0.05 s exposure time.

Statistical analysis, including nonlinear regression {#sec2.4}
----------------------------------------------------

For nonlinear regression and statistical analyses, GraphPad Prism (v. 6.05; GraphPad Software, San Diego, CA) was used. The same program was used to calculate the 95% confidence interval (CI) for a proportion using the modified Wald method. The mean values, without considering the experimental variation at each *s*-value, were used for nonlinear regression fits to the CCF. This procedure was used due to the decreasing number of data points at increasing values of *s* and hence an increased uncertainty at higher *s*-values. If not otherwise stated, the data are given as the mean ± 95% CI.

Results {#sec3}
=======

Evidence suggesting different actin filament flexibility states {#sec3.1}
---------------------------------------------------------------

Numerical values of *Lp*^*f*^ and *Lp*^*p*^ were obtained at 130 mM ionic strength from exponential fits to the CCF (Eq. 1; [Fig. S1](#mmc1){ref-type="supplementary-material"}). For derivation of *Lp*^*f*^ ([Fig. S1](#mmc1){ref-type="supplementary-material"} *A*), the CCF was obtained by observing a large number of filaments floating in solution between two closely spaced coverslips. For derivation of *Lp*^*p*^ ([Fig. S1](#mmc1){ref-type="supplementary-material"} *B*), the CCF was obtained from the paths ([Fig. 1](#fig1){ref-type="fig"}) of filaments propelled by HMM in the IVMA ([@bib5]). In most of the IVMA experiments, the HMM incubation concentration was 120 *μ*g/mL, which is expected to give an isotropic HMM density in the range of 5000--7000 *μ*m^−2^ on TMCS-derivatized surfaces ([@bib42], [@bib43], [@bib44]). Inclusion of methylcellulose in IVMAs has no effect on *Lp*^*p*^ ([@bib5]). Furthermore, since *Lp*^*f*^ values are similar regardless of whether 1 mM MgATP is present or not ([@bib5]), MgATP was not included in measurements of *Lp*^*f*^.

In qualitative agreement with previous results ([@bib5]), phalloidin-free actin filaments exhibited lower *Lp*^*f*^ and *Lp*^*p*^ values than phalloidin-stabilized filaments ([Fig. 2](#fig2){ref-type="fig"}). Furthermore, as was observed previously ([@bib5]), the *Lp*^*p*^ of phalloidin-labeled filaments at 1 mM MgATP was lower than the *Lp*^*f*^. For phalloidin-free filaments, on the other hand, the *Lp*^*p*^ and *Lp*^*f*^ were similar (∼10 *μ*m). The simplest explanation for these results is that the *Lp*^*p*^ is fully determined by the flexural rigidity of the actin filaments ([@bib5], [@bib30], [@bib33]), and that the flexural rigidity of phalloidin-free filaments is unchanged, whereas that of phalloidin-stabilized filaments is reduced upon binding to HMM in an IVMA ([@bib5]).

When \[MgATP\] was reduced from 1 mM to 0.05 mM, the velocity decreased 5- to 10-fold ([Table S1](#mmc1){ref-type="supplementary-material"}) but the fraction of motile filaments increased from 60% to 80% (in the absence of blocking actin or other methods for removing dead rigor-like heads) at 1 mM MgATP to almost 100% at 0.05 mM MgATP. Furthermore, the fraction of very short filaments (≪1 *μ*m) increased at low MgATP ([Fig. 1](#fig1){ref-type="fig"} *C*) due to motility-induced fragmentation. It is clear from [Fig. 1](#fig1){ref-type="fig"} that the very short filaments (≪1 *μ*m; *white arrowheads* in [Fig. 1](#fig1){ref-type="fig"}) follow distinctly more winding paths than the longer filaments ([Movies S1](#mmc2){ref-type="supplementary-material"} and [S2](#mmc3){ref-type="supplementary-material"}). We attribute this finding to repeated pivoting of the very short filaments around temporary single surface attachment points via one myosin head ([@bib31]). Importantly, however, also if filaments shorter than 1 *μ*m were excluded from the analysis, the paths were noticeably more winding on average at low than at high \[MgATP\] ([Fig. 1](#fig1){ref-type="fig"} *E*; [Movies S1](#mmc2){ref-type="supplementary-material"} and [S2](#mmc3){ref-type="supplementary-material"}). This is quantitatively reflected in a markedly reduced path persistence length ([Figs. 2](#fig2){ref-type="fig"} and [S1](#mmc1){ref-type="supplementary-material"} *B*). Thus, *Lp*^*p*^ values at 0.05 mM MgATP, in both the presence and absence of phalloidin, were appreciably lower than any value we have previously observed. The filament length distributions were, however, very similar at low and high \[MgATP\] for filaments included in the quantitative analysis ([Fig. S2](#mmc1){ref-type="supplementary-material"}).

Buckling or related phenomena do not explain low *Lp*^*p*^ at low \[MgATP\] {#sec3.2}
---------------------------------------------------------------------------

The paths of HMM-propelled filaments in the IVMA were governed by the path of the filament front at 0.05 mM MgATP, as was found previously at 1 mM MgATP and also predicted theoretically (([@bib5], [@bib31]); however, see ([@bib34])). This is consistent with the thin appearance of the filament trajectories in [Fig. 1](#fig1){ref-type="fig"} *D*, suggesting that all parts of a filament trace out a similar path. Quantitative evidence is presented in [Fig. S3](#mmc1){ref-type="supplementary-material"}, which shows a \<16 nm average lateral deviation from the path of the leading end per micrometer of filament sliding. This magnitude of deviation can be fully explained by thermal fluctuations of the actin filament segments between subsequent myosin-binding sites (cf. equations in ([@bib20])) together with uncertainty in the estimates of the filament axis position by Gaussian fits to microscopy images. The results in [Fig. S3](#mmc1){ref-type="supplementary-material"} were obtained using the long filaments in [Fig. 1](#fig1){ref-type="fig"}, *C* and *D*, which were selected for highly curved trajectories to maximize the risk of deviations from a single path. The very small lateral deviations found are in accord with the idea ([@bib5], [@bib31]) that fluctuations of the free leading filament end are the major determinant of the filament paths and therefore of the *Lp*^*p*^. The findings shown in [Figs. 1](#fig1){ref-type="fig"} *D* and [S3](#mmc1){ref-type="supplementary-material"} thus argue against appreciable bursts of a nonthermal influence on the filament paths ([@bib34]). Such bursts would include buckling events, i.e., the emergence of unstable mechanical states of the actin filament with lateral bending into a sinusoidal form of unpredictable amplitude ([@bib45]) at compressive forces above certain critical values (see below and [Supporting Materials and Methods](#mmc1){ref-type="supplementary-material"}). More generally, the results in [Fig. S3](#mmc1){ref-type="supplementary-material"} argue against substantial local distortions, independent of origin, that would cause different filament segments to follow different paths ([@bib46]).

Because myosin heads are in a nucleotide-free, strongly bound, postpowerstroke state for a larger fraction of their actin-attached time when \[MgATP\] is lowered, we tested how statically bound heads in a similar state would affect motility and sliding paths. For this purpose, we mixed ordinary HMM with NEM-HMM, which is known ([@bib38]) to act as a strongly bound, noncycling myosin analog that is not dissociated by MgATP. When motility assays at 1 mM MgATP were performed in the presence of NEM-HMM (added as 30% of total \[HMM\]), the motility behavior was qualitatively very different from that observed at low \[MgATP\]. In the latter case, the sliding velocity was substantially reduced compared with that obtained at 1 mM MgATP, but the fraction of motile filaments was increased (see above). In contrast, the inclusion of 30% NEM-HMM caused a smaller reduction in the maximum velocity than in the fraction of motile filaments. Thus, whereas the velocity was reduced by 45% from 7.56 ± 0.30 *μ*m/s to 4.12 ± 0.63 *μ*m/s (*n* = 30 filaments), the fraction of motile filaments was reduced by 79% from 0.65 ± 0.3 to 0.14 ±0.08 (*n* = 5 image frames). Very similar results were obtained with 25% NEM-HMM. In further contrast to the effect of lowered \[MgATP\], different parts of a filament frequently traced out different trajectories in the presence of 25--30% NEM-HMM. These deviations from a single path are readily resolved in standard fluorescence micrographs ([Fig. S4](#mmc1){ref-type="supplementary-material"}) without the need for a detailed analysis as in [Fig. S3](#mmc1){ref-type="supplementary-material"}. Interestingly, similar deviations were present in the supporting movies in a recent study ([@bib34]), in which the behavior was interpreted as local and random injections of energy by interactions of cycling myosin motors with the actin filament. Here, we attribute the deviations in the presence of noncycling NEM-HMM to buckling events caused by MgATP-insensitive myosin heads that did not detach before exerting large resistive forces. This translates into local compressive forces that are above the critical force of buckling for filaments with a rather large average distance between neighboring actin-attached heads, as expected at high \[MgATP\]. This explanation is similar to that proposed for nonthermal fluctuations by Weber et al. ([@bib34]). However, the difference is that we attribute the deviations from one single path (related to a non-Gaussian curvature of the filament) to noncycling cross-bridges, whereas Weber et al. ([@bib34]) attributed them to cycling cross-bridges that are temporarily cross-linked to the actin filament, e.g., as would be expected for postpowerstroke myosin heads. The latter idea is not immediately consistent with our findings. Whereas we saw a limited number of events with different paths of different filament segments (and non-Gaussian curvature) at 1 mM MgATP, we did not detect such events at 0.05 mM MgATP ([Figs. 1](#fig1){ref-type="fig"} *D* and [S3](#mmc1){ref-type="supplementary-material"}), where the time spent by myosin heads in the postpowerstroke state was appreciably increased.

The above results suggest that the free leading end of the actin filament at low \[MgATP\] determines the HMM-propelled filament paths. However, for practical reasons, a detailed analysis of filament paths ([Fig. S3](#mmc1){ref-type="supplementary-material"}) could only be applied to a small fraction of all filaments. Therefore, further analysis is required to more definitively rule out the possibility that subtle effects related to buckling or similar events in a large population of filaments contribute to low *Lp*^*p*^ at low \[MgATP\]. As pointed out above, large angular changes due to buckling are readily identified (e.g., paths with *red arrows* in [Figs. 1](#fig1){ref-type="fig"} *A* and [S4](#mmc1){ref-type="supplementary-material"}) and excluded during either tracking or analysis. In the analysis phase, filaments are excluded if they exhibit angular changes above a certain cutoff value (see [Materials and Methods](#sec2){ref-type="sec"}) ([@bib30]). However, buckling events that cause angular changes below the cutoff are not eliminated. This may distort the distribution of angular updates away from a single Gaussian expected from thermal fluctuations of the leading filament end and increase the width of the distribution (cf. ([@bib34])). Therefore, we analyzed several thousands of angular updates ([Fig. 3](#fig3){ref-type="fig"}). If occasional buckling events contributed to low *Lp*^*p*^ at 0.05 mM MgATP, there would be an increased number of large and abrupt angular changes between tracking points if no cutoff were used to remove them. Furthermore, one would expect an increased deviation from a single Gaussian of the distribution of angular updates (a non-Gaussian path curvature distribution). In contrast, we found a better single Gaussian fit ([Fig. 3](#fig3){ref-type="fig"}, *B* and *C*) at 0.05 mM than at 1 mM MgATP. The lack of systematic deviations from a Gaussian at 0.05 mM MgATP is clear from normally distributed vertical residuals ([Fig. 3](#fig3){ref-type="fig"} *C*) between the fitted curve and experimental data (d'Agostino-Pearson normality test; *p* = 0.0718) and with the mean value of the residuals indistinguishable from zero (*t*-test; *p* = 0.4402). In contrast, at 1 mM MgATP the residuals were nonnormal (*p* = 0.0033), with an average value different from zero (*p* = 0.0063), suggesting systematic deviations. Further, the number of large update events in the ranges of \[−2.5, −1.5\] and \[1.5, 2.5\] rad in [Fig. 3](#fig3){ref-type="fig"} corresponded to only 0.35% ± 0.25% (mean ± 95% CI; *n* = 2588) of all events at 0.05 mM MgATP, compared with 2.17% ± 0.41% (*n* = 4970) at 1 mM MgATP. The good fit to a single Gaussian at low \[MgATP\] is what one would expect for angular updates due to thermal fluctuations of the filament leading end. This is in contrast to what we observed when NEM-HMM (25--30%) was mixed with normal HMM ([Fig. 3](#fig3){ref-type="fig"} *D*). In that case, we found that the sum of two Gaussians gave an appreciably better fit to the data than a single Gaussian. According to the Akaike information criterion (taking into account differences in the sum of squared residuals and applying a penalty for more parameter values in a model), the double Gaussian model was 54 times more likely to fit the data than the single Gaussian. Furthermore, 4.2% ± 0.96% (*n* = 1715) of all update events were in the ranges of \[−2.5, 1.5\] and \[1.5, 2.5\] rad, which is significantly higher than in the absence of NEM-HMM (see above). The improved fit with a double compared with a single Gaussian in the presence of NEM-HMM is also evident from the more symmetrical residuals obtained with a double Gaussian ([Fig. S5](#mmc1){ref-type="supplementary-material"}, *C* and *D*). This suggests a non-Gaussian curvature distribution of the actin filament paths as well as a non-Gaussian curvature distribution of the filament itself ([@bib34]) associated with different paths of different filament segments ([Fig. S4](#mmc1){ref-type="supplementary-material"}).

As a final test to determine whether occasional buckling effects contribute to low *Lp*^*p*^ values at low \[MgATP\], we performed experiments in which the distance between neighboring myosin heads along the actin filament was varied at 0.05 mM MgATP. This was achieved by lowering the HMM incubation concentration from 120 *μ*g/mL to either 40 *μ*g/mL or 20 *μ*g/mL. These changes reduced the HMM surface density by \>35% (40 *μ*g/mL) and \>65% (20 *μ*g/mL) ([Fig. S6](#mmc1){ref-type="supplementary-material"}; *dashed lines*), causing an increased average distance (\<*L*~*f*~\>; Eq. S4) between attached myosin heads by at least 1.5 and 2.9 times, respectively. The critical buckling force, *F*~*c*~ ≈ *π*^2^*Lp*^*f*^ kT/\<*L*~*f*~\>^2^ ([Supporting Materials and Methods](#mmc1){ref-type="supplementary-material"}) is inversely proportional to \<*L*~*f*~\>^2^ (([@bib45], [@bib47], [@bib48])) and may be estimated to 76 pN and 13 pN at an HMM incubation concentration of 120 and 20 *μ*g/mL, respectively, compared with a maximum force of ∼10 pN per myosin head. One would therefore expect an increased risk of buckling and a reduced *Lp*^*p*^ value upon a reduction in the HMM incubation concentration if buckling effects influence *Lp*^*p*^. In contrast, we found no significant effect ([Fig. 4](#fig4){ref-type="fig"}) of the HMM incubation concentration on *Lp*^*p*^.

We conclude that buckling, as defined above, is extremely rare and has no effect on *Lp*^*p*^ at 0.05 mM MgATP. The buckling frequency is higher at 1 mM MgATP and even higher in the presence of NEM-HMM, but is still uncommon. Below (see [Fig. 6](#fig6){ref-type="fig"}), we also consider the possibility that there are random bending effects (other than buckling) close to the leading filament end associated with each myosin head attachment. Such effects may be due to off-axis forces by myosin motors, local conformational changes upon myosin attachment, and bulging of the filament segment between the two leading myosin heads attached to actin. For a detailed account of these possibilities, see [Supporting Materials and Methods](#mmc1){ref-type="supplementary-material"}.

Detailed relationship between *Lp*^*p*^ and \[MgATP\] {#sec3.3}
-----------------------------------------------------

In view of the above results, we felt confident in considering the possibility that actin filament structural states with a lower flexural rigidity dominate during acto-myosin motility at low versus high \[MgATP\]. If so, one would expect a switch from high to low *Lp*^*p*^ values at critical \[MgATP\], with fairly constant values above and below this critical concentration. Studies of *Lp*^*p*^ over a range of MgATP concentrations (0.01--3 mM; [Fig. 5](#fig5){ref-type="fig"} *A*), corresponding to a 30-fold variation in sliding velocity ([Fig. 5](#fig5){ref-type="fig"} *B*), were in reasonable agreement with this idea, with an average *Lp*^*p*^ value almost twofold higher at \[MgATP\] ≥ 0.25 mM than at \[MgATP\] ≤ 0.1 mM (*horizontal solid lines* in [Fig. 5](#fig5){ref-type="fig"} *A*). However, the data ([Fig. 5](#fig5){ref-type="fig"} *A*) suggest that the stepwise \[MgATP\] dependence is superimposed on a graded increase of *Lp*^*p*^ between 0.01 and 1 mM MgATP. Importantly, in a previous study ([@bib5]), no change in *Lp*^*p*^ was seen when the sliding velocity was reduced from 6 to 3 *μ*m/s by lowering the temperature. This suggests that the effect is specific to reduced \[MgATP\] and is not a result of reduced velocity per se.

When \[MgATP\] approaches zero, the fraction of the actin-attached myosin heads in the nucleotide-free AM state (rigor) approaches one ([@bib49]), as also captured by modeling ([Fig. S7](#mmc1){ref-type="supplementary-material"}). If the *Lp*^*p*^ value (\<5 *μ*m) at the lowest tested \[MgATP\] is simply due to binding of myosin heads in the absence of nucleotide, one would expect a similar very low persistence length, *Lp*^*f*^, for actin filaments in solution upon addition of HMM in the absence of MgATP. However, *Lp*^*f*^ was only reduced from 12.67 ± 0.50 *μ*m in the absence of HMM to 9.21 ± 1.39 *μ*m ([Fig. 5](#fig5){ref-type="fig"}, *A* and *C*) upon equimolar binding of HMM to actin filaments that were floating in solution between closely spaced coverslips. The effect of HMM binding on *Lp*^*f*^ in solution depended on the HMM/actin molar ratio, with the regression coefficient for *Lp*^*f*^ versus HMM concentration ([Fig. 5](#fig5){ref-type="fig"} *C*) being significantly below zero (*p* = 0.0078). We also estimated the *Lp*^*f*^ of actin filaments in solution upon mixing with 0.5 *μ*M HMM and 0.01 mM MgATP, and found that the *Lp*^*f*^ was similar to that obtained for bare actin filaments ([Fig. 5](#fig5){ref-type="fig"} *C*). Increasing the HMM concentration to 4 *μ*M in the presence of MgATP had complex effects ([Fig. S8](#mmc1){ref-type="supplementary-material"}; [Movies S4](#mmc5){ref-type="supplementary-material"}, [S5](#mmc6){ref-type="supplementary-material"}, [S6](#mmc7){ref-type="supplementary-material"}, and [S7](#mmc8){ref-type="supplementary-material"}; see also ([@bib6], [@bib10]))) that precluded reliable estimates of *Lp*^*f*^. The effects included occasional high-amplitude bending events, presumably due to actin-myosin interactions. These events were associated with filament fragmentation, an effect that was more pronounced at 1 mM than at 0.05 mM MgATP. Additionally, calculations suggested low myosin head labeling of the actin filament ([Table S3](#mmc1){ref-type="supplementary-material"}). Finally, there was evidence for the presence of a fraction of dead (rigor-like) myosin heads (which are likely to always exist in HMM preparations; [Fig. S8](#mmc1){ref-type="supplementary-material"} *C*; cf. [Fig. 1](#fig1){ref-type="fig"}).

Modeling of *Lp*^*p*^ at different \[MgATP\] and HMM incubation concentrations {#sec3.4}
------------------------------------------------------------------------------

As indicated by the data in [Fig. 5](#fig5){ref-type="fig"}, the stepwise decrease in *Lp*^*p*^ is superimposed on a continuous decrease with lowered \[MgATP\]. One possible basis for this continuous effect is local structural changes, e.g., stochastic bending or local conformational changes of the actin filament that occur upon each myosin head attachment ([Fig. S9](#mmc1){ref-type="supplementary-material"}). Such an effect is expected to increase with reduced \[MgATP\] because the reduced velocity, without a reduction in the myosin head attachment rate, causes more myosin head attachments for a given sliding distance.

We modeled the mechanism underlying this phenomenon by assuming that each myosin head attachment adds a random angular change, with variance *V*~*xb*~, to that attributed to thermal motion. Under these conditions the apparent persistence length, *Lp*^*app*^ (corresponding to *Lp*^*p*^), would vary with the average distance, \<*x*\>~1~, between subsequent myosin head attachments at the filament front, according to a hyperbolic relationship (Eq. S9):$$\text{Lp}^{\text{app}} = Lp^{f}\frac{\left\langle x \right\rangle_{1}}{\left\langle x \right\rangle_{1} + Lp^{f}V_{xb}}.$$Here, \<*x*\>~1~ is approximated from experimental data using \<*x*\>~1~ = *v*~*f*~ \<*t*\>~1~, where *v*~*f*~ is the average sliding velocity and \<*t*\>~1~ is the average time between subsequent myosin head attachments at the filament front (Eq. S2). The quantity \<*x*\>~1~ is correlated with the average steady-state distance, \<*L*~*f*~\> (see above) between myosin heads along the actin filament (excluding filament ends; cf. ([@bib50])), but the latter value (Eq. S4) is higher. Whereas there are experimental uncertainties in both *v*~*f*~ and \<*t*\>~1~, the changes in \<*t*\>~1~ upon an altered HMM incubation concentration depend primarily on the myosin head density, which is quite reproducible between experiments for TMCS-derivatized surfaces ([Fig. S6](#mmc1){ref-type="supplementary-material"}).

Plots of *Lp*^*p*^ versus \<*x*\>~1~ for all \[MgATP\] and HMM incubation concentrations are depicted in [Fig. 6](#fig6){ref-type="fig"}. The solid horizontal straight lines in [Fig. 6](#fig6){ref-type="fig"} *A* correspond to fits obtained under the assumptions that *V*~*xb*~ = 0 (i.e., no structural effect of individual head attachments) with one actin filament state at \[MgATP\] ≤ 0.1 mM and another state at \[MgATP\] ≥ 0.25 mM (cf. [Fig. 5](#fig5){ref-type="fig"}). Clearly, the fit is poor, with each line being outside the 95% CIs of several individual data points. We also attempted to fit the data assuming the same values of both *Lp*^*f*^ and *V*~*xb*~ (*V*~*xb*~ \> 0) at high and low \[MgATP\] (*gray lines* in [Fig. 6](#fig6){ref-type="fig"} *A*), but the fit was also rather poor in this case (see details below). The results are better reproduced by two mechanisms operating simultaneously: 1) a stepwise decrease in *Lp*^*f*^ when \[MgATP\] is reduced to \<0.25 mM superimposed on 2) an additional reduction of *Lp*^*p*^ with reduced \[MgATP\] due to more myosin head attachments per sliding distance (*V*~*xb*~ \> 0). Based on these assumptions, we first fitted Eq. 2 to all of the data obtained at \[MgATP\] ≤ 0.1 mM, including all HMM incubation concentrations (20--120 *μ*g/mL; cf. [Fig. 4](#fig4){ref-type="fig"}). The resulting fit ([Fig. 6](#fig6){ref-type="fig"} *B*) was excellent, giving *Lp*^*f*^ = 8.69 ± 1.33 *μ*m (mean ± 95% CI) and *V*~*xb*~ = 0.0010 ± 0.0005. Also, the data point obtained in the absence of phalloidin fell on the line even though it was not included in the fitting procedure. If we then fixed the value of *V*~*xb*~ at 0.0010, assuming that this parameter is independent of \[MgATP\], we obtained a good fit at \[MgATP\] ≥ 0.25 mM with *Lp*^*f*^ =12.7 ± 1.7 *μ*m. When we instead allowed *V*~*xb*~ to vary in the fitting procedure, also at high \[MgATP\] and including the data point in the absence of phalloidin, we obtained the following parameter values at \[MgATP\] ≥ 0.25 mM (*solid gray lines* in [Fig. 6](#fig6){ref-type="fig"} *B*): *Lp*^*f*^ =13.9 ± 16.4 *μ*m *V*~*xb*~ = 0.0014 ± 0.0045. Whereas these values have appreciable uncertainties, the similarity of the mean *V*~*xb*~ value to that obtained at low \[MgATP\] is consistent with the idea that the numerical value of *V*~*xb*~ is independent of \<*x*\>~1~. One may relate the numerical value to real structural changes by realizing that *V*~*xb*~ = 0.001 corresponds to a standard deviation of 0.03 rad, i.e., a root mean-square change in filament angular direction of 1.8° per myosin head attachment.

Based on the Akaike criterion (see above), two different models at \[MgATP\] ≥ 0.25 mM and \[MgATP\] ≤ 0.1 mM ([Fig. 6](#fig6){ref-type="fig"} *B*) are 13 times more likely to be correct than one given model at different \[MgATP\] (*gray line* in [Fig. 6](#fig6){ref-type="fig"} *A*). This is in agreement with the overlap of the 95% CIs of 10 out of 12 of the individual data points with the lines representing two models ([Fig. 6](#fig6){ref-type="fig"} *B*), but an overlap with the gray line (one model) in [Fig. 6](#fig6){ref-type="fig"} *A* in only six out of 12 cases. Additionally, the variances of the vertical deviations between the data and the one-model (*gray*, [Fig. 6](#fig6){ref-type="fig"} *A*) and two-model (*blue*, [Fig. 6](#fig6){ref-type="fig"} *B*) fits were 1.15 and 0.753, respectively, i.e., appreciably lower for the two-model case (see [Table S2](#mmc1){ref-type="supplementary-material"}).

As illustrated in [Fig. 2](#fig2){ref-type="fig"} (see also ([@bib5], [@bib21])), phalloidin increases the flexural rigidity of actin filaments observed floating in solution between two narrowly spaced (\<5 *μ*m) coverslips. However, the differences between path persistence lengths in the presence and absence of phalloidin under otherwise similar conditions are considerably smaller ([Fig. 1](#fig1){ref-type="fig"}) ([@bib5]). Therefore, data obtained in the presence and absence of phalloidin fit into the same general picture when a range of conditions are considered as in [Fig. 6](#fig6){ref-type="fig"}.

We also attempted to account for the data in [Fig. 6](#fig6){ref-type="fig"} by assuming that the \[MgATP\] dependence is solely due to the \[MgATP\] dependence of *V*~*xb*~, i.e. assuming that *Lp*^*f*^ is independent of \[MgATP\]. However, we obtained poorer fits to the experimental data regardless of whether we assumed a stepwise change of *V*~*xb*~ as a function of \[MgATP\] or a continuous change as a function of \<*x*\>~1~ ([Fig. S10](#mmc1){ref-type="supplementary-material"}).

To summarize, the analyses in [Figs. 6](#fig6){ref-type="fig"} and [S10](#mmc1){ref-type="supplementary-material"} suggest that 1) different *Lp*^*f*^ values at \[MgATP\] ≤ 0.1 mM (low *Lp*^*f*^) and \[MgATP\] ≥ 0.25 mM (high *Lp*^*f*^), and 2) \[MgATP\]-independent bending of the actin filament upon each myosin head attachment.

Discussion {#sec4}
==========

Key findings in relation to previous work {#sec4.1}
-----------------------------------------

A central finding of this work was the substantial reduction of *Lp*^*p*^ upon a decrease of \[MgATP\] to ≤0.1 mM. This effect was considerably greater than the decrease in the flexural rigidity (*Lp*^*f*^) of phalloidin-stabilized actin filaments upon HMM binding in solution. The effect of reduced \[MgATP\] on *Lp*^*p*^ is not attributed to nonthermal contributions of a type considered recently ([@bib34], [@bib46]). The results we obtained with NEM-HMM instead suggest that such contributions with anomalous filament curvatures ([@bib34]) are associated with an inhomogeneous HMM population with a high ratio of statically noncycling to cycling myosin heads. This idea is consistent with the virtual disappearance of anomalous curvatures at low \[MgATP\]. Under these conditions, the number of cycling myosin heads attached at each given point in time is increased ([@bib35]) compared with the situation at high \[MgATP\], whereas the number of dead, rigor-like, nonfunctional heads is not. This increased fraction of cycling heads also explains the larger fraction of motile filaments at low \[MgATP\].

After considering recently raised issues ([@bib34], [@bib46]) and experimental complications ([Figs. 1](#fig1){ref-type="fig"}, [3](#fig3){ref-type="fig"}, [4](#fig4){ref-type="fig"}, and [S2--S6](#mmc1){ref-type="supplementary-material"}), we focused on mechanisms that seem to provide the simplest explanations for the low *Lp*^*p*^ at low \[MgATP\]. First, the results in [Fig. 6](#fig6){ref-type="fig"} are consistent with two different structural states of the actin filament in the IVMA, with a switch between these states occurring between 0.1 and 0.25 mM MgATP, possibly due to global, cooperative changes in the entire actin filament structure. This is in agreement with previous evidence for different actin filament structural states ([@bib7], [@bib12], [@bib13], [@bib24]) with cooperative switching between them ([@bib1], [@bib24], [@bib51]). Superimposed on the stepwise transition between 0.1 and 0.25 mM MgATP, there was a graded reduction in *Lp*^*p*^ with reduced \[MgATP\]. The latter effect was correlated with the number of myosin head attachments per sliding distance at the actin filament front ([Fig. 6](#fig6){ref-type="fig"}), as well as to the average density of the myosin heads along the filament. One possible basis for this effect is local structural changes ([@bib7]), e.g., local stochastic bending or local conformational changes in F-actin structure, associated with each myosin head binding independently of the MgATP concentration ([Fig. S8](#mmc1){ref-type="supplementary-material"}). This idea is consistent with the good fits of Eq. 2 to the data obtained by assuming two different *Lp*^*f*^ values but one given value of *V*~*xb*~ ([Fig. 6](#fig6){ref-type="fig"} *B*). We also tested alternative models ([Fig. 6](#fig6){ref-type="fig"}) that did not involve a change in *Lp*^*f*^ upon reduced \[MgATP\]. However, none of these models gave as good fit to the data as that obtained with two different *Lp*^*f*^ values at high and low \[MgATP\].

The results accord with three different structural states of the actin filaments ([Fig. S10](#mmc1){ref-type="supplementary-material"}). These states are characterized by low (8--9 *μ*m), intermediate (∼10 *μ*m), or high (\>∼12 *μ*m) persistence lengths. The state with the highest rigidity exists only in the presence of phalloidin and the absence of myosin binding ([Fig. 2](#fig2){ref-type="fig"}; see ([@bib5]) for details), whereas the state with the lowest flexural rigidity is observed at low \[MgATP\] in the IVMA and with HMM in solution in the absence of MgATP. The possibility that the state is mechanically similar to that observed upon cofilin binding ([@bib22]) and strong binding of a number of side-attached actin-binding proteins on a surface ([@bib23]) needs further consideration.

Possible role of two myosin heads during HMM-induced sliding at low \[MgATP\] {#sec4.2}
-----------------------------------------------------------------------------

One may consider the idea that both heads of a given HMM molecule bind sequentially during in vitro sliding at low \[MgATP\], possibly associated with bending of the filament to accommodate the two heads sterically. Such bending would contribute to the low *Lp*^*p*^ value at low \[MgATP\]. However, there is previous evidence against two-headed binding under these conditions, based on perfect hyperbolic fits of velocity-\[MgATP\] data ([@bib35]). Nor do the data presented here suggest that two-headed binding plays a role. If such binding appreciably contributes to a lowered path persistence length in the motility assay at low \[MgATP\], one would expect a progressive increase of the effect when \[MgATP\] is reduced from 0.1 to 0.01 mM. Under these conditions, there would thus be one effect due to the increased number of two-headed attachments and another effect due to the increased number of attachments per sliding distance. We found that the latter effect is sufficient to explain the change in *Lp*^*p*^ in the range of \[MgATP\] from 0.01 to 0.1 mM (*lower curve* in [Fig. 6](#fig6){ref-type="fig"} *B*). Further, if two-headed binding is important, it would occur only in a fraction of the binding events. As such, it would be expected to cause a double-Gaussian distribution of angular updates in the sliding direction, as observed in the presence of NEM-HMM but not at low \[MgATP\].

Mechanisms underlying the \[MgATP\] dependence of *Lp*^*f*^ {#sec4.3}
-----------------------------------------------------------

Changes in the dominant myosin state ([@bib7], [@bib12], [@bib13]) or changes in filament tension alone ([@bib52], [@bib53], [@bib54]) may modify the actin filament structure and affect the flexural rigidity. Therefore, we sought to determine how the predominant chemomechanical actin-myosin states in the IVMA differed at \[MgATP\] ≤ 0.1 mM and \[MgATP\] ≥ 0.25 mM. To that end, we used a recent cross-bridge model ([@bib35]) that accounts well for a range of experimental findings. Both versions of this model, with linear and nonlinear cross-bridge elasticity, predict that the total fraction of attached myosin heads exhibits an accelerated increase below 0.25 mM MgATP. Furthermore, the fraction of heads in the nucleotide-free state (the AM-state) is predicted to increase above ∼50% in the range of 0.1--0.25 mM MgATP. In this context, it is of interest to note that the actin-attacked myosin heads in the model ([@bib35]) exhibit a wide range of strains, causing local forces on the actin filament ([Fig. S9](#mmc1){ref-type="supplementary-material"} *C*). This leads us to hypothesize that nucleotide-free AM states exerting a spectrum of forces on the filament, including compressive forces, are mechanistically important for the high-flexibility state at low \[MgATP\]. However, importantly, as argued above, this effect is not a complication attributed to buckling effects. Instead (see also ([@bib5], [@bib31], [@bib33])), we believe that structural changes at the myosin-binding region of actin allosterically affect nearby filament segments, including the myosin-free and tension-free leading end, reducing the flexural rigidity of this segment.

The idea that compressive forces due to myosin heads in the AM state are important for reducing *Lp*^*f*^ is consistent with the finding that HMM binding to actin filaments in solution (with some interhead strain) in the absence of MgATP reduces *Lp*^*f*^, whereas binding of myosin subfragment 1 (one-headed) ([@bib10]) does not. The idea also fits with the similarity of the *Lp*^*f*^ value at low \[MgATP\] in the IVMA (from the analysis in [Fig. 6](#fig6){ref-type="fig"}) to the *Lp*^*f*^ value of actin filaments floating in solution in the presence of HMM without MgATP ([Fig. 5](#fig5){ref-type="fig"} *C*). In both cases, the AM state dominates and there are compressive forces due either to interhead strain (in solution) or strain due to myosin heads in the postpowerstroke state that counteract propulsive forces by other heads.

Large-amplitude bending events, as observed by us and others ([@bib6], [@bib10]) in the presence of HMM and MgATP in solution, occur with very sparse myosin head binding (cf. [Table S3](#mmc1){ref-type="supplementary-material"}), and various other complexities affect the interpretation (see above and ([@bib10])). Nevertheless, one may argue that similar bending events are important in the IVMA. However, given the large amplitude of the bending events in solution and the considerably higher myosin head density in the motility assay, one would then expect the *Lp*^*p*^ to be appreciably lower than the *Lp*^*f*^. This is in direct conflict with what we observed for phalloidin-free filaments ([Fig. 2](#fig2){ref-type="fig"}).

Functional significance and relevance for nanotechnological applications {#sec4.4}
------------------------------------------------------------------------

MgATP concentrations of ≤0.1 mM are unlikely to be relevant in cells even under severely fatiguing conditions or hypoxia ([@bib55]), arguing against adaptive values of the increased flexibility of actin filaments at low \[MgATP\]. However, one possibility that deserves to be tested in future studies is that this property has been retained during evolution ([@bib56]) from nonmuscle to muscle actin isoforms. In this context, it is of interest to note that nonmuscle myosin II exhibits low physiological velocities (\<1 *μ*m/s) and slow detachment kinetics similar to those of fast skeletal myosin II at low \[MgATP\] ([@bib57]). Furthermore, in the same context, it is of interest to note that actin filament disassembly ([@bib3]) due to interaction with nonmuscle myosin II at the trailing end of nonmuscle cells seems to be important for normal motility of nonmuscle cells. Such disassembly would be facilitated by a reduced filament flexural rigidity, as was recently noted in the presence of cofilin ([@bib58]). Disassembly is actually also observed ([@bib59]) in the IVMA when actin filaments are propelled by fast skeletal muscle HMM at \[MgATP\] ≤ 0.1 mM (see also [Fig. 1](#fig1){ref-type="fig"}).

The data presented here extend our knowledge ([@bib5], [@bib60]) about how experimental conditions (e.g., filament length, \[MgATP\], dead myosin heads, and \[HMM\]; cf. [Figs. 1](#fig1){ref-type="fig"}, [2](#fig2){ref-type="fig"}, [3](#fig3){ref-type="fig"}, [4](#fig4){ref-type="fig"}, and [5](#fig5){ref-type="fig"}) affect the path persistence length and path curvature of HMM-propelled filaments. This is important for nanotechnological applications of actin and myosin, such as biosensing ([@bib61], [@bib62]) and parallel computation ([@bib63]), due to the central role of *Lp*^*p*^ in determining how effectively myosin-propelled actin filaments are guided through nanofabricated networks ([@bib32], [@bib46], [@bib61], [@bib64]).

Conclusions {#sec5}
===========

We have further validated a recently developed approach ([@bib5], [@bib30], [@bib31], [@bib33]) to obtain the actin filament flexural rigidity from the path persistence length, and demonstrated that it provides access to conditions that may not be readily probed otherwise. Using this approach, we have provided evidence for three different actin filament flexibility states, the most flexible of which becomes significantly populated during myosin-induced actin filament sliding at low \[MgATP\]. The results are in accordance with the idea that actin filaments dynamically switch between a range of structural states depending on, e.g., the imposed tension and binding of myosin heads in the different states. Furthermore, the effect of altered distance between subsequent myosin attachment points suggests that long-range cooperative structural changes are superimposed on short-range changes associated with the attachment of each myosin head. The results also shed light on recently studied phenomena that suggest nonthermal contributions to the filament paths ([@bib34]). Finally, the data relate to important physiological phenomena and are of value for nanotechnological applications using actin and myosin.
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![Actin filaments propelled by HMM in the IVMA at 1 and 0.05 mM MgATP. (*A*) Fluorescence micrograph (0.2 s) illustrating the starting point of filaments (1 mM MgATP) whose trajectories are illustrated in (*B*). The white arrow and white arrowhead point to typical filaments \>1 *μ*m and \<1 *μ*m long, respectively. (*B*) Trajectories of filaments at 1 mM MgATP obtained by overlaying five subsequent image frames in a sequence starting with that in (*A*). The white arrow and white arrowhead point to trajectories of corresponding filaments in (*A*). Gray arrows indicate trajectories with abrupt changes in sliding direction toward the end of the observed path due to pinning of filaments on rigor-like dead heads. Such rare trajectories were excluded from the analysis (see text). (*C*) Snapshot as in (*A*) but illustrating the starting point of trajectories in (*D*) (0.05 mM MgATP; arrow and arrowhead as described in *A*). (*D*) Trajectories of filaments at 0.05 mM MgATP obtained by overlaying 20 subsequent image frames in a sequence starting with that in (*C*). A larger number of frames were used to compensate for the lower velocity compared with that obtained at 1 mM MgATP (arrow and arrowhead as described in *B*). (*E*) Trajectories of long (\>1 *μ*m) filaments (excluding those with abrupt changes in sliding direction) from (*A*)*--*(*D*), replotted based on manual tracking in MATLAB. Trajectories at 1 mM MgATP and 0.05 mM MgATP are shown in black and gray, respectively, with the starting point translated to the origin after rotation for the initial sliding direction to be along the horizontal axis. Note that there are more winding paths on average at 0.05 mM MgATP. No methods were used in these experiments to remove or block dead rigor-like heads, e.g., precentrifugation of HMM with ATP and actin or inclusion of blocking actin. All grayscale images were similarly enhanced for contrast and brightness by histogram stretching using ImageJ ([@bib71]).](gr1){#fig1}

![Persistence lengths of filaments in solution (*Lp*^*f*^) and path persistence lengths (*Lp*^*p*^) with (*black bars*, Ph+) and without (*open bars*, Ph−) phalloidin. Comparison of persistence lengths under different conditions obtained from fits such as those shown in [Fig. S1](#mmc1){ref-type="supplementary-material"}, *A* and *B*. Data (mean ± 95% CI) from at least 200 independent filaments (*Lp*^*f*^) or filament paths (*Lp*^*p*^). Only filaments longer than 1 *μ*m were included in the analysis of *Lp*^*p*^. Other analysis criteria as in ([@bib30]).](gr2){#fig2}

![Relative frequency distributions for angular updates in the sliding direction between image frames for phalloidin-stabilized actin filaments. (*A*) Data uncorrected for different velocities and interframe times. Black, 1 mM MgATP (time between frames: 0.2 s; sliding velocity 11.73 *μ*m s^−1^); brighter line and symbols, 0.05 mM MgATP (time between frames: 0.8 s; sliding velocity 1.94 *μ*m s^−1^). Curves represent Gaussian fits to the data. Total number of events (angular updates): 4970 at \[MgATP\] = 1 mM and 2588 at \[MgATP\] = 0.05 mM. Inset: upper tails of distributions shown at higher resolution. (*B*) Data in (*A*) at 0.05 mM \[MgATP\] were multiplied by 1.2 = $\sqrt{\frac{11.73x0.2}{1.94x0.8}}$ to correct for the shorter distance moved between tracking points compared with 1 mM \[MgATP\] (correction only for the width of the Gaussian, not for the total area under curve). The HMM incubation concentration is 120 *μ*g/mL in (*A*) and (*B*). Note the higher number of large, abrupt changes in the sliding direction (tails of distribution) at high \[MgATP\] (*black*) compared with low \[MgATP\] (*brighter line* and *symbols*). (*C*) Vertical residuals (connected by lines for clarity) between data for 1 mM MgATP (*black*) or 0.05 mM MgATP (*bright*) and Gaussian curves in (*B*). Note the larger systematic deviations between the data and Gaussian fit at 1 mM than at 0.05 mM MgATP, particularly for large angular updates (\<−1.5 rad and \>1.5 rad). For a statistical analysis of residuals, see text. (*D*) Distribution as in (*A*) but for actin filaments propelled by HMM at 1 mM MgATP in the presence of 25--30% NEM-HMM after removal of stationary filaments ([Fig. S5](#mmc1){ref-type="supplementary-material"}, *A* and *B*). Average velocity: 3.87 *μ*m/s. Time between updates: 0.4 s. Bright curve: single Gaussian fit. Black curve: sum of two Gaussians assuming that the mean of each Gaussian component is constant and equal to 0 rad. To see this figure in color, go online.](gr3){#fig3}

![*Lp*^*p*^ at 0.05 mM MgATP and different HMM incubation concentrations. One actin preparation was tested at all HMM incubation concentrations and another was tested at 40 *μ*g/mL. Each experimental point (mean ± 95% CI) was obtained by fitting Eq. 1 to the CCF for \>200 independent filament paths. See also [Fig. S2](#mmc1){ref-type="supplementary-material"}.](gr4){#fig4}

![Effects of varied \[MgATP\]. (*A*) *Lp*^*p*^ plotted against \[MgATP\] on a logarithmic scale obtained after HMM incubation at 120 *μ*g/mL. Each experimental point (mean ± 95% CI) was obtained by fitting Eq. 1 to the CCF for \>200 independent filament paths. Solid symbols: phalloidin-stabilized filaments. Open symbols: phalloidin-free filaments. Solid lines: mean *Lp*^*p*^ values for \[MgATP\] ≤ 0.1 mM and \[MgATP\] ≥ 0.25 mM, respectively. Upper and lower dashed lines: *Lp*^*f*^ for phalloidin-stabilized filaments in solution before and after full labeling with HMM in the absence of MgATP. (*B*) Average velocities for phalloidin-stabilized filaments in (*A*) plotted against \[MgATP\]. (*C*) Effect of HMM binding on *Lp*^*f*^ with actin filaments floating in solution between closely spaced (\<5 *μ*m) coverslips (see [Materials and Methods](#sec2){ref-type="sec"}). Black symbols and lines: no MgATP. Number of filaments: 0 nM, 809; 2.5 nM, 75; 5 nM, 132; 10 nM, 85. Actin monomer concentration: 10 nM. The regression line (*solid black line*) is shown with the 95% CI (*dotted lines*). Slope: −0.33 ± 0.13 *μ*m nM^−1^, significantly below zero (*p* = 0.0078). The slope was significantly (*p* = 0.0452) below zero even if the point on the vertical axis was omitted from the linear regression analysis. Gray symbols and line: experiment with (*n* = 341 filaments) and without (*n* = 231 filaments) addition of HMM at 0.5 *μ*M to actin filaments in solution (20 nM) in the presence of 0.01 mM MgATP.](gr5){#fig5}

![Experimental path persistence lengths versus the calculated average sliding distance \<*x*\>~1~ between subsequent myosin head attachments. Solid symbols: with phalloidin (Ph+). Open clear symbols: without phalloidin (Ph−). (*A*) Assumptions that *V*~*xb*~ = 0 (*black horizontal lines*) or that there is one value of both *V*~*xb*~ and *Lp*^*f*^ that is independent of \[MgATP\] (*gray curved lines*). Black horizontal lines represent the mean value (*Lp*^*p*^ = *Lp*^*f*^ in Eq. 2) of data points at \[MgATP\] ≥ 0.25 mM (data within *dashed ellipse*) and \[MgATP\] ≤ 0.1 mM, respectively. Gray lines represent fits to all data using one value of both *V*~*xb*~ and *Lp*^*f*^, either including the data without phalloidin (*dashed line*) or not (*solid line*). (*B*) Fits of Eq. 2 to the same data as in (*A*) under the assumption that the *Lp*^*f*^ values are different at \[MgATP\] ≥ 0.25 mM and \[MgATP\] ≤ 0.1 mM (*dashed and solid gray lines*). Dashed gray lines represent fits limited to experiments in the presence of phalloidin (Ph+), with the numerical value of *V*~*xb*~ obtained from the fit at \[MgATP\] ≤ 0.1 (*lower curve*) and then fixed at this value when fitting Eq. 2 for \[MgATP\] ≥ 0.25 mM (*upper curve*). Solid gray lines represent fits to Ph− and Ph+ data obtained with both *Lp*^*f*^ and *V*~*xb*~ varied at \[MgATP\] ≤ 0.1 mM and \[MgATP\] ≥ 0.25. Each experimental point (mean ± 95% CI) was obtained by fitting Eq. 1 to the CCF for \>200 independent filament paths. HMM incubation concentration: 120 *μ*g/mL (*black*), 40 *μ*g/mL (*light gray in black circles*), or 20 *μ*g/mL (*dark gray*). For details on the fits, see text and [Table S2](#mmc1){ref-type="supplementary-material"}.](gr6){#fig6}
